Pharmafile Logo
Pharmafocus logo
Advanced Search
shutterstock_87495637

AstraZeneca jettisons two heart drugs to Cheplapharm in $400m deal

October 30, 2020
Manufacturing and Production, Medical Communications, Sales and Marketing AstraZeneca, Cheplapharm

AstraZeneca is set to sell the rights to its AT1 subtype angiotensin II receptor antagonist Atacand (candesartan cilexetil) and Atacand …

News
800px-european_commission_flags_1

EU approves Zejula as a first-line monotherapy maintenance treatment in advanced ovarian cancer

October 30, 2020
Medical Communications

The European Commission has approved GlaxoSmithKline’s Zeljula as a first line monotherapy maintenance treatment for adult patients with ovarian cancer …

News
49798220211_23b94b0fb8_b

New study suggests UK Government’s ‘Eat Out to Help Out’ scheme increased coronavirus infection rates

October 30, 2020
Medical Communications

The Eat Out to Help Out scheme contributed to a significant rise in new coronavirus cases according to a study …

News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

October 30, 2020
Medical Communications

The top ten news stories this week focus on COVID-19 studies, as new research has found that over 80% of …

News
heinz-woodward-front1

David Woodward joins GAMA Healthcare as Board Business Advisory Consultant and CEO Mentor

October 29, 2020
Business Services

GAMA Healthcare have announced that David Woodward has been brought on as Board Business Advisory Consultant and CEO Mentor. Woodward …

Appointment
europe-1395916_640

European Commission greenlights Insmed’s Arikayce for nontuberculous mycobacterial lung infections

October 29, 2020
Sales and Marketing Arikayce, EU, lungs, pharma

The European Commission (EC) has given approval to Insmed Incorporated’s Arikayce (liposomal 590mg nebuliser dispersion) for the treatment of nontuberculous …

News
tumour-infiltrating_lymphocytes_-_2_--_very_high_mag

NICE says test people with womb cancer for Lynch syndrome

October 29, 2020
Medical Communications

New guidance from the National Institute of Health and Care Excellence says that women with womb cancer should be tested …

News
800px-social_distancing_queueing_for_the_supermarket_j

Nearly 100,000 people catching coronavirus every day in England, new study suggests

October 29, 2020
Research and Development

Nearly 100,000 people are being infected with COVID-19 each day according to a new study from Imperial College London.  Named …

News
bugbuster

FDA approves Sanofi’s ivermectin head lice treatment for over-the-counter use

October 29, 2020
Sales and Marketing

The FDA has approved Sanofi’s Sklice (ivermectin) for over-the-counter use.  Sklice is a single-use lotion that includes ivermectin 0.5% as …

News
takeda_usa_pharmaceuticals_u

Takeda commits to deliver 50 million doses of Moderna’s COVID-19 vaccine in Japan

October 29, 2020
Manufacturing and Production, Sales and Marketing COVID-19, Japan, Moderna, Takeda, Vaccine

Takeda has made a commitment with Japan’s Ministry of Health, Labor and Welfare (MHLW) to deliver 50 million doses of …

News
robertson_1

Redx Pharma appoints Dr Jane Robertson as Chief Medical Officer

October 29, 2020
Research and Development

Redx Pharma has announced the appointment of Dr Jane Robertson as its new Chief Medical Officer at the company. Robertson …

Appointment
vaccination-1215279_960_720

GSK and Sanofi promise 200m COVID-19 vaccines to international COVAX initiative

October 28, 2020
Manufacturing and Production, Research and Development COVAX, COVID-19, GSK, Sanofi

Sanofi and GSK have committed 200 million doses of their adjuvanted recombinant protein-based COVID-19 vaccine to the COVAX Facility, a …

News

Novartis collaborates with Molecular Partners to develop therapies to use against COVID-19

October 28, 2020
Research and Development

Novartis and Molecular Partners AG have announced that they will develop, commercialise and manufacture Molecular’s anti-COVID-19 DARPin programme, which consists …

News
lilly_building_with_american_flag_web

US reserves 300,000 doses of Lilly’s COVID-19 treatment in $375 million deal

October 28, 2020
Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Eli Lilly, US, pharma

The US Government has signed a $375 million deal with Eli Lilly to buy 300,000 700mg doses of bamlanivimab, its …

News

80% of COVID-19 patients in study were vitamin D-deficient

October 28, 2020
Research and Development

New research has found that over 80% of COVID-19 patients in a recent study had a vitamin D deficiency.  The …

News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

October 28, 2020
Research and Development

The coronavirus news this week focuses on clinical trials testing potential vaccines, with the University of Oxford and AstraZeneca stating …

News
pharmafocus_november_2020_cover

The November 2020 issue of Pharmafocus is available to read free online now!

October 27, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Biden, Pharmafocus, Trump, UK, US election, brexit, pharma, remdesivir

The latest monthly edition of Pharmafocus is available to read for free online now!

News
sanofi_hq__boetie_hall_web

Sanofi’s Dupixent shows strength at Phase 3 in eosinophilic esophagitis

October 27, 2020
Manufacturing and Production Dupixent, Sanofi, pharma

Sanofi has lifted the curtain on new Phase 3 data for Dupixent (dupilumab), showing that the drug met all of …

News
800px-eli_lilly_corporate_center_indianapolis_indiana_usa_2

Eli Lilly antibody treatment fails COVID-19 study

October 27, 2020
Manufacturing and Production

The US Government is putting an early end to clinical trials testing Eli Lilly’s antibody drug in COVID-19 patients.  The …

News
brain_mri_131749_t1

New trial to test if cancer drug can effectively treat hallucinations in Parkinson’s patients

October 27, 2020
Manufacturing and Production Parkinson's, Parkinson's UK

A new study is set to go ahead that will test if ondansetron is safe and effective in treating Parkinson’s …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026